133 related articles for article (PubMed ID: 22750097)
21. NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas.
Engels K; Knauer SK; Loibl S; Fetz V; Harter P; Schweitzer A; Fisseler-Eckhoff A; Kommoss F; Hanker L; Nekljudova V; Hermanns I; Kleinert H; Mann W; du Bois A; Stauber RH
Cancer Res; 2008 Jul; 68(13):5159-66. PubMed ID: 18593915
[TBL] [Abstract][Full Text] [Related]
22. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
23. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.
Yang L; Dan HC; Sun M; Liu Q; Sun XM; Feldman RI; Hamilton AD; Polokoff M; Nicosia SV; Herlyn M; Sebti SM; Cheng JQ
Cancer Res; 2004 Jul; 64(13):4394-9. PubMed ID: 15231645
[TBL] [Abstract][Full Text] [Related]
24. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.
Mitsuuchi Y; Johnson SW; Selvakumaran M; Williams SJ; Hamilton TC; Testa JR
Cancer Res; 2000 Oct; 60(19):5390-4. PubMed ID: 11034077
[TBL] [Abstract][Full Text] [Related]
25. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
26. Intranuclear domains involved in inositol lipid signal transduction.
Maraldi NM; Zini N; Santi S; Manzoli FA
Eur J Histochem; 2000; 44(1):81-7. PubMed ID: 10868296
[No Abstract] [Full Text] [Related]
27. Targeting AKT protein kinase in gastric cancer.
Almhanna K; Strosberg J; Malafa M
Anticancer Res; 2011 Dec; 31(12):4387-92. PubMed ID: 22199303
[TBL] [Abstract][Full Text] [Related]
28. Phospholipid signaling in leukocytes.
Cockcroft S
Curr Opin Hematol; 1996 Jan; 3(1):48-54. PubMed ID: 9372051
[TBL] [Abstract][Full Text] [Related]
29. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics.
Mita AC; Mita MM; Nawrocki ST; Giles FJ
Clin Cancer Res; 2008 Aug; 14(16):5000-5. PubMed ID: 18698017
[TBL] [Abstract][Full Text] [Related]
30. Girdin, a novel actin-binding protein, and its family of proteins possess versatile functions in the Akt and Wnt signaling pathways.
Enomoto A; Ping J; Takahashi M
Ann N Y Acad Sci; 2006 Nov; 1086():169-84. PubMed ID: 17185515
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways.
McCubrey JA; Steelman LS; Kempf CR; Chappell WH; Abrams SL; Stivala F; Malaponte G; Nicoletti F; Libra M; Bäsecke J; Maksimovic-Ivanic D; Mijatovic S; Montalto G; Cervello M; Cocco L; Martelli AM
J Cell Physiol; 2011 Nov; 226(11):2762-81. PubMed ID: 21302297
[TBL] [Abstract][Full Text] [Related]
32. Human intestinal epithelial crypt cell survival and death: Complex modulations of Bcl-2 homologs by Fak, PI3-K/Akt-1, MEK/Erk, and p38 signaling pathways.
Harnois C; Demers MJ; Bouchard V; Vallée K; Gagné D; Fujita N; Tsuruo T; Vézina A; Beaulieu JF; Côté A; Vachon PH
J Cell Physiol; 2004 Feb; 198(2):209-22. PubMed ID: 14603523
[TBL] [Abstract][Full Text] [Related]
33. EGFR signaling and drug discovery.
Lurje G; Lenz HJ
Oncology; 2009; 77(6):400-10. PubMed ID: 20130423
[TBL] [Abstract][Full Text] [Related]
34. The role of phosphatidylinositol 3-kinase signaling pathways in pancreatic cancer.
Sun C; Rosendahl AH; Andersson R; Wu D; Wang X
Pancreatology; 2011; 11(2):252-60. PubMed ID: 21625196
[TBL] [Abstract][Full Text] [Related]
35. [Drug resistance mediated by survival- and growth-promoting signaling pathways].
Fujita N
Gan To Kagaku Ryoho; 2009 Apr; 36(4):567-71. PubMed ID: 19381028
[TBL] [Abstract][Full Text] [Related]
36. Chemoattractants and chemorepellents act by inducing opposite polarity in phospholipase C and PI3-kinase signaling.
Keizer-Gunnink I; Kortholt A; Van Haastert PJ
J Cell Biol; 2007 May; 177(4):579-85. PubMed ID: 17517960
[TBL] [Abstract][Full Text] [Related]
37. Phospholipid-based signaling in plants.
Meijer HJ; Munnik T
Annu Rev Plant Biol; 2003; 54():265-306. PubMed ID: 14502992
[TBL] [Abstract][Full Text] [Related]
38. Consequences of feedback in signal transduction for targeted therapies.
Klinger B; Blüthgen N
Biochem Soc Trans; 2014 Aug; 42(4):770-5. PubMed ID: 25109956
[TBL] [Abstract][Full Text] [Related]
39. The Many Roles of Type II Phosphatidylinositol 4-Kinases in Membrane Trafficking: New Tricks for Old Dogs.
Minogue S
Bioessays; 2018 Feb; 40(2):. PubMed ID: 29280156
[TBL] [Abstract][Full Text] [Related]
40. PtdIns(4)P signalling and recognition systems.
Lenoir M; Overduin M
Adv Exp Med Biol; 2013; 991():59-83. PubMed ID: 23775691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
